title: Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte d'Ivoire.
abstract: OBJECTIVE
  To compare sexual behaviours of HIV-infected patients in Côte d'Ivoire whether or not they had access to antiretroviral treatment (ARV).
  
  
  METHODS
  Cross-sectional survey using face-to-face interviews among all patients, informed of their HIV serostatus, attending the eight health centers in charge of HIV care in Abidjan and Bouaké. Univariate comparisons of declared sexual behaviours during the prior 6 months between the 164 ARV-treated and the 547 non-ARV-treated respondents. Multiple logistic regressions to identify factors related to sexual abstinence in the total sample and to unprotected sexual intercourse in the subsample of sexually active respondents during the same period were performed.
  
  
  RESULTS
  More than half of the 711 respondents (53.0%) declared an absence of sexual activity during the previous 6 months, with this proportion being significantly higher among women (60.6%), and among both men (85.7%) and women (92.4%) who were not living in a stable relationship. Among the 334 sexually active patients, 49.7% declared a low frequency of sexual intercourse ('once a month or less'), and 43.7% declared at least one episode of unprotected sexual intercourse. In multivariate analysis, recent diagnosis of HIV infection (< 9 months), having only one sexual partner and not knowing her/his serostatus, high alcohol consumption, absence of episodes of acute morbidity, not participating in household's expenditures and not being ARV-treated were significantly related to a higher likelihood of HIV-related risky sexual behaviours.
  
  
  CONCLUSIONS
  Sexual abstinence is the preventive strategy of choice for a majority of HIV-infected patients aware of their serostatus and consulting for care in Côte d'Ivoire. In these patients, access to ARV is not associated with an increase in HIV-related risky sexual behaviours.
authors.affiliation: INSERM U 379, University of the Mediterranean, Marseille France. moatti@marseille.inserm.fr
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Moatti
authors.forename: Joanne
authors.initials: J
authors.lastname: Prudhomme
authors.forename: Djénéba Coulibaly
authors.initials: DC
authors.lastname: Traore
authors.forename: Anne
authors.initials: A
authors.lastname: Juillet-Amari
authors.forename: Hortense Aka-Dago
authors.initials: HA
authors.lastname: Akribi
authors.forename: Philippe
authors.initials: P
authors.lastname: Msellati
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D017280:Condoms / Q000706:statistics & numerical data; D003430:Cross-Sectional Studies; D005260:Female; D005602:France; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000523:psychology*; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D008875:Middle Aged; D012309:Risk-Taking; D012746:Sexual Abstinence; D012725:Sexual Behavior
chemical_list: D019380:Anti-HIV Agents